Evidence map›Paper›PMID 40917105›Full record

ArticleJournal of the Endocrine Society2025

Sex Differences in Ketogenic Diet Response Reveal Gonadal Hormone Interaction With FGF21 in Mice.

Yuan Zhang, Jesse D Cochran, Rhonda A Souvenir, Warren Tai, Ruiyou Xia, Brendan S Gladwin, Natalie B Barton, Renata O Pereira, E Dale Abel

Abstract read
In one paragraph

Article in Journal of the Endocrine Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. A ketogenic diet reduces hepatic alcohol metabolism and alcohol consumption in rats.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yuan ZhangDepartment of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.ORCID https://orcid.org/0000-0003-0067-2096
Jesse D CochranDepartment of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.
Rhonda A SouvenirDepartment of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.
Warren TaiDepartment of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.
Ruiyou XiaDepartment of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.
Brendan S GladwinDepartment of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.
Natalie B BartonDepartment of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.
Renata O PereiraDepartment of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.
E Dale AbelDepartment of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA 90095, USA.ORCID https://orcid.org/0000-0001-5290-0738

Funding

CARDIOVASCULAR SCIENTIST TRAINING PROGRAMT32HL007895 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SHIVKUMAR, KALYANAM, WATSON, KAROL E · 1998 to 2023
$9.2M
OPA1 an Estrogen-Mediated Modulator of Platelet HyperactivationR33HL141783 · NHLBI · UNIVERSITY OF IOWA · PI ABEL, E DALE, RONDINA, MATTHEW THOMAS · 2020 to 2022
$2.2M
The role of the integrated stress response in brown adipose tissue-mediated metabolic adaptationsR01DK125405 · NIDDK · UNIVERSITY OF IOWA · PI PEREIRA ALAMBERT, RENATA · 2020 to 2024
$1.9M
Role of the mitochondrial fusion protein optic atrophy (OPA)-1 in platelet hyperactivity and thrombosisF32HL128008 · NHLBI · UNIVERSITY OF IOWA · PI SOUVENIR, RHONDA ANDREA · 2015 to 2016
$103k
NHLBI NIH HHS F32 HL128008NHLBI NIH HHS R33 HL141783NHLBI NIH HHS T32 HL007895NIDDK NIH HHS R01 DK125405
6 · The paper itself

Abstract

Although indicated as adjunctive therapy for seizure disorders, ketogenic diets (KDs) have gained popularity for weight loss and mitigating the metabolic risks associated with severe obesity. However, efficacy, durability, and long-term consequences are incompletely understood. In preclinical models, most studies have included only male mice, precluding an understanding of sex-specific responses to KD. In this study, we investigated sex differences in response to a high-fat, low carbohydrate, low-protein KD using male and female C57BL/6J mice. Despite equivalent circulating levels of β-hydroxybutyrate, male mice exhibited weight loss characterized by loss of fat mass and lean mass in concert with increased energy expenditure. In contrast, female mice exhibited increased fat mass and body weight on the KD. Male mice manifested increased insulin sensitivity, without reducing glucose excursions during glucose tolerance testing, in concert with decreased glucose-stimulated insulin release. In contrast, females developed glucose intolerance and insulin resistance relative to control females. Following oophorectomy, female mice lost weight on KD but remained glucose intolerant. Orchidectomy in male mice reversed weight loss in KD males. Circulating fibroblast growth factor 21 (FGF21) concentrations were increased in males but not females on KD and correlated with increased FGF21 expression in brown adipose tissue. These findings demonstrate that the metabolic effects of KD are sex-specific and suggest that gonadal hormones modulate the adaptive response to ketogenic diets via FGF21 signaling.

Indexed as

FGF21gonadal hormonesinsulin resistanceketogenic dietsex differences

Identifiers

PMID40917105
PMCPMC12411846

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.